Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells
RNA-seq (gene expression) · human · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 24 samples: 24 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cellsSignal transduction and targeted therapy · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281230_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1182774 and SRA study SRP543565. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 24 sample titles: 24 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8615375 Healthy donor 1, 28zeta CAR, un-stimulated
- GSM8615376 Healthy donor 1, 28delta CAR, un-stimulated
- GSM8615377 Healthy donor 1, 28epsilon CAR, un-stimulated
- GSM8615378 Healthy donor 1, 28gamma CAR, un-stimulated
- GSM8615379 Healthy donor 1, 28zeta CAR, stimulated with target cells
- GSM8615380 Healthy donor 1, 28delta CAR, stimulated with target cells
- GSM8615381 Healthy donor 1, 28epsilon CAR, stimulated with target cells
- GSM8615382 Healthy donor 1, 28gamma CAR, stimulated with target cells
- GSM8615383 Healthy donor 2, 28zeta CAR, un-stimulated
- GSM8615384 Healthy donor 2, 28delta CAR, un-stimulated
- GSM8615385 Healthy donor 2, 28epsilon CAR, un-stimulated
- GSM8615386 Healthy donor 2, 28gamma CAR, un-stimulated
- GSM8615387 Healthy donor 2, 28zeta CAR, stimulated with target cells
- GSM8615388 Healthy donor 2, 28delta CAR, stimulated with target cells
- GSM8615389 Healthy donor 2, 28epsilon CAR, stimulated with target cells
- GSM8615390 Healthy donor 2, 28gamma CAR, stimulated with target cells
- GSM8615391 Healthy donor 3, 28zeta CAR, un-stimulated
- GSM8615392 Healthy donor 3, 28delta CAR, un-stimulated
- GSM8615393 Healthy donor 3, 28epsilon CAR, un-stimulated
- GSM8615394 Healthy donor 3, 28gamma CAR, un-stimulated
- GSM8615395 Healthy donor 3, 28zeta CAR, stimulated with target cells
- GSM8615396 Healthy donor 3, 28delta CAR, stimulated with target cells
- GSM8615397 Healthy donor 3, 28epsilon CAR, stimulated with target cells
- GSM8615398 Healthy donor 3, 28gamma CAR, stimulated with target cells
- GSE307776 ZAP327 signaling domain–driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models 12 samples shares antitumor, chimeric, receptor, antigen
- GSE266456 Co-STARs: Combining the advantages of chimeric antigen and T cell receptors for cancer targeting 108 samples shares chimeric, receptor, antigen
- GSE289406 Anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy bb21217 for relapsed and refractory multiple myeloma: results from the phase 1 CRB-402 study 75 samples shares chimeric, receptor, antigen
- GSE278512 Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity 45 samples shares chimeric, receptor, antigen
- GSE255323 Transcriptional responses of T cells activated via CD22-specific T cell receptor compared to CD22-specific chimeric antigen receptor 36 samples shares chimeric, receptor, antigen
- GSE314995 Disulfide-directed multicyclic peptides for chimeric antigen receptors targeting solid tumors 27 samples shares chimeric, receptor, antigen
- GSE313107 AMPK agonism optimizes the in vivo activation and anti-leukemia efficacy of chimeric antigen receptor T cells 12 samples shares chimeric, receptor, antigen
- GSE294657 Chimeric antigen receptor-microglia targeting glioblastoma within cortical organoid 4 samples shares chimeric, receptor, antigen
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.